Page 95 Cite

Suggested Citation: "Appendix B: Polling Results." Institute of Medicine. 2010. Extending the Spectrum of Precompetitive Collaboration in Oncology Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12930.

Appendix B
Polling Results

At two points during the conference, participants attending the workshop in person were given individual keypads to respond to a series of questions posed by John Wagner, chair of the workshop planning committee. He noted that he was sampling a very small population (22 responses were obtained) biased toward seeing the value to collaborations, so the results featured below, though of interest, are by no means scientific or representative of the community of biomedical researchers.

Questions	Responses
Questions	Percentage	Count
What organization do you represent?
Government	0	0
Industry	32	7
Academia	18	4
Nonprofit	23	5
Other	27	6
Have you personally participated in a precompetitive collaboration?
Yes	52	11
No	48	10
Has your institution/company participated in a precompetitive collaboration?
Yes	77	17
No	23	5

Page 96 Cite

Questions	Responses
Questions	Percentage	Count
How important do you feel precompetitive collaboration is to biomedical research?
Not at all important	5	1
Somewhat important	0	0
Important	5	1
Very important	23	5
Critical	68	15
Which research activity do you feel can benefit most from precompetitive collaboration?
Bioinformatics/software development	4	1
Data generation/collection efforts	35	8
Basic research	17	4
Translational/disease-focused research	35	8
Product-oriented research	9	2
What do you see as the biggest hurdle to precompetitive collaboration in biomedicine?
Individualist/competitive culture among academics	30	6
Proprietary culture of industry	25	5
Intellectual property issues	25	5
Academic promotion/tenure process	15	3
Publications	0	0
Patient privacy concerns	5	1
How relevant/applicable are industry collaborations, such as SEMATECH, to biomedical research?
Not at all important	0	0
Somewhat important	16	3
Important	16	3
Very important	42	8
Critical	26	5
How relevant/applicable are prizes, such as InnoCentive offers, to biomedical research?
Not at all important	0	0
Somewhat important	42	8
Important	26	5
Very important	21	4
Critical	11	2

Page 97 Cite

Questions	Responses
Questions	Percentage	Count
How relevant/applicable are True Open Source Collaborations, such as Linux, to biomedical research?
Not at all important	0	0
Somewhat important	26	5
Important	26	5
Very important	21	4
Critical	26	5